Fig. 5From: Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II studyProportion of patients who fulfilled response criteria after 1-year of follow-up. Percentage of patients on benralizumab treatment represented in categories according to the number of different response criteria fulfilled after 1-year of follow upBack to article page